What are the characteristic MRI findings of cervical myelopathy (CMRO) on T1-weighted, T1 fat‑suppressed, STIR, and T2-weighted imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MRI Findings in Cervical Myelopathy Across Different Sequences

In cervical myelopathy, T2-weighted and STIR sequences show hyperintense intramedullary signal at the compression site, while T1-weighted images show hypointensity when there is irreversible cord damage, and T1 fat-suppressed sequences are primarily used post-gadolinium to detect active inflammation with characteristic "pancake-like" enhancement patterns.

T2-Weighted Imaging Findings

T2-weighted sequences are the workhorse for detecting cervical myelopathy and show:

  • Hyperintense intramedullary signal at the level of maximal spinal cord compression 1, 2
  • Signal changes that may be reversible (representing edema/gliosis) or irreversible (representing myelomalacia/necrosis) 2
  • Lesions should be focal with clearly demarcated borders to be diagnostically significant 3
  • The hyperintensity typically appears as cigar-shaped on sagittal images and wedge-shaped on axial images 3

Critical prognostic distinction: The number of vertebral segments showing T2 hyperintensity matters significantly. Multilevel T2 hyperintensity predicts poor surgical outcome 1, 4, while single-level changes have conflicting prognostic value 1.

T1-Weighted Imaging Findings

T1-weighted sequences without fat suppression reveal structural damage:

  • Hypointense signal at the compression site indicates irreversible cord damage (myelomalacia, necrosis, cavitation) and portends the worst prognosis 1, 2
  • Combined T1 hypointensity with T2 hyperintensity at the same level is a particularly poor prognostic indicator 1, 4
  • T1 sequences are optimal for detecting spinal cord atrophy (transverse area <45 mm²), which predicts poor surgical outcomes 1
  • Normal T1 signal suggests potentially reversible pathology 2

Key clinical pearl: T1 hypointensity represents the point of no return—these patients have the worst surgical outcomes regardless of decompression 2.

STIR (Short Tau Inversion Recovery) Findings

STIR sequences are highly sensitive to free water content and inflammation:

  • Shows hyperintense signal at sites of cord edema and active inflammation 5
  • Superior to T2-weighted imaging for detecting increased signal intensity, with higher signal intensity ratios 6
  • Particularly valuable in diabetic patients with cervical myelopathy, where STIR has better prognostic value than T2-weighted sequences 6
  • More susceptible to flow-related artifacts than conventional T2-weighted sequences, which can lead to false-positive interpretations 7

The STIR sequence demonstrates better capability than T2-weighted imaging for detecting intramedullary signal changes, though both sequences show similar predictive value for outcomes in non-diabetic patients 6.

T1 Fat-Suppressed Imaging (Post-Gadolinium)

T1-weighted sequences with fat suppression following gadolinium administration reveal:

  • Active inflammation through contrast enhancement 5
  • Characteristic "pancake-like" enhancement pattern on sagittal images and circumferential pattern on axial images, located within areas of T2 signal abnormality 8
  • This enhancement pattern is highly specific for spondylotic myelopathy when present at the level of compression 8
  • Enhancement is less frequent in spinal cord lesions compared to brain lesions and typically associated with new clinical symptoms 7

Important caveat: Contrast enhancement in cervical spondylotic myelopathy appears immediately at and below the level of stenosis 9. However, contrast is typically not required for diagnosis of spondylotic myelopathy—it's most useful when differentiating from inflammatory or infectious etiologies 9.

Algorithmic Approach to Interpretation

Step 1: Examine T2-weighted images first

  • Identify hyperintense signal at compression site
  • Count number of vertebral segments involved (multilevel = poor prognosis)
  • Assess lesion morphology (should be focal, cigar-shaped)

Step 2: Correlate with T1-weighted images

  • Look for hypointensity at same level as T2 changes
  • If T1 hypointensity present = irreversible damage, worst prognosis
  • Measure cord cross-sectional area (<45 mm² = poor prognosis)

Step 3: Consider STIR if available

  • Particularly in diabetic patients
  • Provides superior detection of signal changes
  • Calculate signal intensity ratio for prognostic assessment

Step 4: Reserve T1 fat-suppressed post-gadolinium for specific scenarios

  • When inflammatory/infectious etiology suspected
  • To confirm spondylotic etiology (look for pancake-like enhancement)
  • Not routinely needed for diagnosis

Common Pitfalls to Avoid

  • Don't confuse diffuse ill-defined signal changes with focal lesions—only focal, well-demarcated lesions should be considered pathological 3
  • Don't rely on T2 hyperintensity alone for prognosis—must correlate with T1 findings and number of segments involved 1, 4
  • Don't assume all T2 hyperintensity is irreversible—regression of T2 hyperintensity postoperatively correlates with better outcomes 2
  • Don't overlook flow artifacts on STIR—these can mimic pathology 7
  • Don't order gadolinium routinely—it's not needed for typical spondylotic myelopathy diagnosis 9

The evidence consistently demonstrates that combined assessment across multiple sequences provides the most accurate diagnosis and prognosis, with T1 hypointensity being the single most important negative prognostic indicator 1, 2, 4.

References

Guideline

acr appropriateness criteria® myelopathy: 2021 update.

Journal of the American College of Radiology, 2021

Related Questions

Given my cervical spine MRI showing central/posterior spinal cord T2 hyperintensity at C3‑C5, bilateral cerebellar white‑matter T2 hyperintensities, a focal disc herniation with foraminal stenosis, and a small C7 facet bone‑marrow edema, what further evaluation and management should I pursue?
I have normal complete blood count and comprehensive metabolic panel, mildly elevated creatinine, positive antinuclear antibody with RNP antibodies, and MRI findings showing nonspecific T2 hyperintensity in the cervical spinal cord (C3‑C5) and cerebellar white matter. I am experiencing progressive proximal muscle weakness in the thighs, hips, shoulders, and distal muscles, with occasional leg shaking and back pain. What is the most likely diagnosis, and should I be concerned about amyotrophic lateral sclerosis while awaiting further imaging and specialist appointments?
Given minimal increased T2 signal in the cervical spinal cord (C3‑C5) and cerebellar white matter, a positive anti‑RNP antibody (4.7 U) with otherwise negative ENA panel, and normal CBC, CMP, liver enzymes, creatine kinase, ferritin, high‑sensitivity C‑reactive protein, and homocysteine, do these findings explain my arm fasciculations and leg shaking on awakening, and what is the likely diagnosis and prognosis?
Do the C4‑C5 shallow posterior disc and osteophyte complex with left lateral recess compression and mild left foraminal narrowing, along with the C5‑C6 shallow posterior disc herniation, explain the patient’s left arm pain and left hand numbness/tingling as cervical radiculopathy?
Band-like sensory disturbance around the trunk is characteristic of which myelopathy, and if non‑compressive what is the usual cause?
What is the appropriate management for a 25-year-old female with dengue (NS1 and IgM positive, IgG negative) presenting with hypotension, severe anemia (hemoglobin 6.8 g/dL) and low hematocrit (19 %)?
What measures can be taken to reduce the risk of complications when treating leptospirosis?
What is the recommended tapering schedule for lorazepam (starting at 12 mg daily) after resolution of alcohol withdrawal symptoms?
How is chronic recurrent multifocal osteomyelitis (CRMO) diagnosed and treated in pediatric patients?
What is the equivalent of the Russian drug Ascorutin (a combination of vitamin C and rutin)?
In a patient with post‑transjugular intrahepatic portosystemic shunt (TIPS) fever and blood cultures showing gram‑positive cocci, what empirical antibiotic regimen should be initiated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.